BIO-key International (NASDAQ:BKYI – Get Free Report) and TD SYNNEX (NYSE:SNX – Get Free Report) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, profitability, valuation, dividends and earnings.
Volatility and Risk
BIO-key International has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Comparatively, TD SYNNEX has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500.
Institutional & Insider Ownership
26.5% of BIO-key International shares are owned by institutional investors. Comparatively, 84.0% of TD SYNNEX shares are owned by institutional investors. 3.7% of BIO-key International shares are owned by company insiders. Comparatively, 1.0% of TD SYNNEX shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Analyst Recommendations
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
BIO-key International | 0 | 0 | 0 | 0 | 0.00 |
TD SYNNEX | 0 | 2 | 8 | 0 | 2.80 |
TD SYNNEX has a consensus target price of $149.30, suggesting a potential upside of 2.78%. Given TD SYNNEX’s stronger consensus rating and higher possible upside, analysts plainly believe TD SYNNEX is more favorable than BIO-key International.
Valuation and Earnings
This table compares BIO-key International and TD SYNNEX”s revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
BIO-key International | $6.93 million | 0.73 | -$4.30 million | ($1.28) | -0.58 |
TD SYNNEX | $58.45 billion | 0.20 | $689.09 million | $8.56 | 16.97 |
TD SYNNEX has higher revenue and earnings than BIO-key International. BIO-key International is trading at a lower price-to-earnings ratio than TD SYNNEX, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares BIO-key International and TD SYNNEX’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
BIO-key International | -60.92% | -92.10% | -45.86% |
TD SYNNEX | 1.21% | 11.58% | 3.18% |
Summary
TD SYNNEX beats BIO-key International on 12 of the 14 factors compared between the two stocks.
About BIO-key International
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
About TD SYNNEX
TD SYNNEX Corporation operates as a distributor and solutions aggregator for the information technology (IT) ecosystem. The company offers personal computing devices and peripherals, mobile phones and accessories, printers, supplies, and endpoint technology software; and data center technologies, such as hybrid cloud, security, storage, networking, servers, technology software, and converged and hyper-converged infrastructure, as well as computing components. It also provides systems design and rack integration, build-to-order, and configure-to-order assembly; and thermal testing, power-draw testing, burn-in, and quality and logistics support. In addition, the company offers outsourced fulfillment, virtual distribution, and direct ship to end-users; shipping documents generation, multi-level serial number tracking, and configured products and online order and shipment tracking, as well as turn-key logistics solutions. Further, it provides public cloud solutions in productivity and collaboration, IaaS, or Infrastructure as a Service, PaaS, or Platform as a Service, SaaS, or Software as a Service, security, mobility, IoT, and other hybrid solutions. Additionally, the company offers online services; provides net terms, third party leasing, floor plan financing, and letters-of-credit backed financing and arrangement; and leases products and provides device-as-a-service, as well as offers direct mail, external media advertising, reseller product training, targeted telemarketing campaigns, national and regional trade shows, trade groups, database analysis, print on demand services, and web-based marketing. It serves value-added resellers, corporate resellers, government resellers, system integrators, direct marketers, retailers, and managed service providers. The company was formerly known as SYNNEX Corporation and changed its name to TD SYNNEX Corporation in September 2021. TD SYNNEX Corporation was founded in 1974 and is headquartered in Fremont, California.
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.